Aimedis is an AI backed, blockchain and smart contract supported medical ecosystem, that changes the way patients, doctors, and hospitals communicate, connect and handle information. Using the Aimedis platform, users can store, secure and share their medical information only with the people they want to share it with by using the Aimedis right management system. Beside the records, AImedis offers videochat and communication with other patients and doctors, online prescriptions, online appointments, learning content, the inclusion of fitness trackers and devices like ECG or bloodpressure monitors into the system, while all transactions inside the system are backed by our porprietary private AIMChain blockchain, while the token is bound to a public blockchain (Aimedis dual-blockchain model). AIMSocial will be the new incentivised and decentralized medical social network where patients can help other patients and get rewarded for it, while the system is supported by AI.

Founded in 2019 Retreeb is a sustainable fintech. We develop a decentralized, simple and sustainable mobile payment method. It is a free payment service for consumers and relies on a multi-local stablecoin network and Fantom's infrastructure. It allows its users to act in accordance with the universal values of ethics, sharing and solidarity.

ORION is a new kind of blockchain investment platform that combines the best features of exchanges, brokerages, and instant trading apps. The platform is built around a liquidity aggregator connected to all of the major crypto exchanges, as well as its own internal decentralized exchange, enabling users to gain the best price for their trades from a single portal. Along with powerful tools for portfolio management, ORION offers exceptional security, convenience, and flexibility. The platform is suitable for experienced traders, institutional investors, and newcomers alike.

Review.Network is a project that aims to create a unique trusted high-intelligence user-company feedback platform based on blockchain and AI technologies. Review.Network provides direct communication between companies and customers, that helps carry on efficient top-tier market research feedback without any mediator. Our model also directly rewards participants for their valuable feedback. The platform's community can gain coins by producing content and working with quality reviews on the Review.Network platform. With the smart recommendation system implemented, it is easier for members to find the best goods and services with ease. The REW is the digital currency of the Review.Network platform. Companies purchase coins to conduct market research on the platform and reward users in exchange for the feedback they leave.

TillBilly aims to bring blockchain to the mainstream retail. TillBilly is a Stellar based digital payments network with a unique point of sale hardware terminal that empowers everyday shoppers to make contactless payments, automatically get digital receipts (tax invoices) and collect loyalty reward points, without the complexity or price volatility associated with cryptocurrencies TillBilly bypasses the middlemen Merchant Services providers (card processing companies, payment gateways) who charge high processing fees per transaction (1.5% - 3.5%) and provides an ultra low fee payments network, so the shopper pays less, and the merchant gets more Protects both shoppers and merchants against any cryptocurrency price volatility. Provides a seamless way of funding wallets within app, and making payments through our proprietary tap-and-go (NFC) payment terminals. Complexities of blockchain and cryptocurrencies are hidden from shoppers and merchants.

MediLOT is a health data protocol that aims to solve the concerns of Electronic Health Records (EHR). Current EHR systems are fragmented, centralised and lack patient ownership. Through a dual blockchain solution, MediLOT incorporates Artificial Intelligence capabilities onboard its control and data layers which allows the equitable sharing of health data. The MediLOT ecosystem will consist of patients, healthcare providers, researchers and commercial companies.